Exhibit 99.1
FOR IMMEDIATE RELEASE
Company Contact: Investor Relations Contact:
PHC, Inc. Liolios Group, Inc.
Bruce A. Shear, President & CEO Ron Both
Tel: 978-536-2777 Tel: 949-574-3860
PHC REPORTS RECORD FINANCIAL RESULTS
FOR THE FIRST QUARTER OF FISCAL 2008
Peabody, Mass. -- November 8, 2007 -- PHC, Inc., d.b.a. Pioneer Behavioral
Health (AMEX:PHC), a leading provider of inpatient and outpatient behavioral
health services and pharmaceutical research, announced financial results for the
first quarter ended September 30, 2007.
Q1 2008 Financial and Operational Highlights
o Record first quarter revenues of $12.7 million, increased 26% vs. Q1 '07
o Record first quarter net income of $0.8 million or $0.04 per share,
increased 182% vs. Q1 '07
o First quarter patient care revenue increased 29% vs. Q1 '07
o Patient days increased 5% primarily due to an increase of 20 additional
beds vs. Q1 '07
o Balance sheet continued to strengthen: Total liabilities reduced by $1.5
million vs. Q4 '07, primarily due to revolving debt reduction
o Construction of the Seven Hills Behavioral Institute near Las Vegas, Nevada
remains on track to open in early 2008. Seven Hills is projected to
contribute annualized revenue of approximately $12 million, with higher
margins than PHC's other inpatient facilities.
o Company purchased 150,000 PHC treasury shares in the open market.
Key Financial Indicators
(In thousands, except per-share amounts.)
Q1 2008 vs. Q1 2007 Q1 2008 Q1 2007 Change % Change
Consolidated revenues $12,704 $10,062 $2,642 26%
Patient care revenues $10,143 $ 7,876 $2,267 29%
Net Income Before Taxes $ 1,307 $ 466 $ 841 180%
Net Income $ 800 $ 283 $ 517 182%
Earnings per share - Basic $ 0.04 $ 0.02 $ 0.02 100%
Earnings per share - Diluted $ 0.04 $ 0.01 $ 0.03 300%
3
First Quarter Financial Results
For the three months ended September 30, 2007 and compared to the same quarter a
year ago:
Total net revenue from operations increased 26% to $12.7 million, as compared to
$10.1 million for the three months ended September 30, 2006. This increase is
primarily attributable to an increase in net revenue of the Company's patient
care segment, which was up 29% to $10.1 million from $7.9 million in the same
year-ago period. Revenue from the pharmaceutical studies segment increased 35%
to $1.4 million as compared to $1.1 million for the same quarter last year.
Contract support services revenue provided by the Company's Wellplace subsidiary
remained relatively stable at $1.1 million.
Income from operations for the quarter totaled $1.4 million, an increase of 151%
from the $0.6 million reported for the same period last year. Net income before
taxes increased 180%, to a record $1.3 million from $0.5 million for the
year-ago same period.
Net income for the quarter was $0.8 million, or $0.04 per fully diluted share
(based on 20.6 million fully diluted shares), an increase of 182% compared to
net income of $0.3 million, or $0.01 per fully diluted share (based on 19.3
million shares) for the first quarter last year.
Total operating expenses for the quarter increased 19% to $11.3 million from the
$9.5 million reported during the first quarter of last year. Included in this
increase were expenses of approximately $100,000 related to new programs and
services associated with new contracts and the Seven Hills Behavioral Institute.
The Company's provision for doubtful accounts decreased to $0.4 million for the
quarter, compared to $0.5 million in the same quarter last year. The percentage
of bad debt expense to net patient care revenue for the quarter was 4% as
compared to 6% for the same period last year.
Patient care operating expenses increased 31% as compared to the same year-ago
period, reflecting the expenses related to new major contracts. Pharmaceutical
patient care expenses increased 25% and contract support expenses decreased 4%.
The increase in patient care expense reflects the Company's investments in its
Las Vegas market initiatives, including the Seven Hills project and the
Company's 10-year, $80 million agreement with Behavioral Healthcare Options
announced in December 2006.
"This quarter was another record in both revenue and profit," said Bruce A.
Shear, Pioneer's president and CEO. "It was driven by a strong 29% expansion of
our patient care revenues. The increase in our net profit versus the same
quarter last year, once again demonstrates the return on our investment in our
Las Vegas market expansion. This occurred despite incurring another $100,000 in
expenses designed to enhance future returns. We continue to expect the income
expansion trend to be sustained as our new Seven Hills facility comes on line in
2008. Given this and our days sales outstanding - and debt balances declining,
we remain in a strong position for growth."
Teleconference Information
PHC will host a conference call today at 4:30 p.m., Eastern Time. A question and
answer session will follow management's presentation.
4
To participate in the call, dial the appropriate number 5-10 minutes prior to
the start time, request the PHC conference call and provide the conference ID.
Domestic callers: 1-800-683-1525
International callers: 1-973-872-3197
Conference ID#: 9414911
A web simulcast of the call can be accessed via PHC's website at
www.phc-inc.com. The call will be available for replay starting at 7:30 p.m.
Eastern Time until December 8, 2007:
Toll-Free Replay number: 1-877-519-4471
International Replay number: 1-973-341-3080
Replay PIN #: 9414911
If you have any difficulty connecting with the conference call or webcast,
please contact the Liolios Group at 949-574-3860.
About PHC, Inc.
Pioneer Behavioral Health operates companies that provide inpatient and
outpatient behavioral health care services, clinical research and Internet- and
telephonic-based referral services. The companies contract with national
insurance companies, government payors, and major transportation and gaming
companies, among others, to provide such services. For more information, please
visit www.phc-inc.com.
Statement under the Private Securities Litigation Reform Act of 1995
This press release may include "forward-looking statements" that are subject to
risks and uncertainties. Forward-looking statements include information about
possible or assumed future results of the operations or the performance of the
Company and its future plans and objectives. Various future events or factors
may cause the actual results to vary materially from those expressed in any
forward-looking statements made in this press release. For a discussion of these
factors and risks, see the company's annual report on Form 10-K for the most
recently ended fiscal year.
5
PHC, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, June 30,
ASSETS 2007 2007
____ ____
(unaudited)
Current assets:
Cash and cash equivalents $ 2,759,303 $ 3,395,173
Accounts receivable, net of allowance
for doubtful accounts of $2,878,902 at
September 30, 2007 and $3,764,585 at
June 30, 2007 6,694,412 6,524,387
Pharmaceutical receivables 1,723,159 1,942,268
Prepaid expenses 687,390 688,600
Other receivables and advances 960,527 868,628
Deferred income tax asset 1,596,796 2,015,000
____________ __________
Total current assets 14,421,587 15,434,056
Accounts receivable, non-current 35,000 35,000
Other receivable 85,619 91,697
Property and equipment, net 2,371,375 2,121,191
Deferred financing costs, net of amortization
of $179,136 at September 30, 2007 and $143,377
June 30, 2007 578,105 613,865
Customer relationships, net of amortization of
$410,000 at September 30, 2007 and $380,000 at
June 30, 2007 1,990,000 2,020,000
Goodwill 3,508,576 3,508,576
Other assets 3,305,609 3,465,356
____________ __________
Total assets $26,295,871 $27,289,741
============ ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 1,322,824 $ 1,261,841
Current maturities of long-term debt 1,120,110 1,134,300
Revolving credit note 562,496 1,518,742
Deferred revenue 270,492 433,301
Current portion of obligations under capital
leases 195,024 205,858
Accrued payroll, payroll taxes and benefits 1,744,386 1,631,693
Accrued expenses and other liabilities 1,458,130 1,702,772
____________ __________
Total current liabilities 6,673,462 7,888,507
Long-term debt 623,455 831,387
Obligations under capital leases 187,612 226,706
Deferred tax liability 93,000 93,000
____________ __________
Total liabilities 7,577,529 9,039,600
____________ __________
Stockholders' equity:
Preferred Stock, 1,000,000 shares authorized,
none issued or outstanding -- --
Class A common stock, $.01 par value, 30,000,000
shares authorized, 19,622,076 and 19,622,076
shares issued at September 30, 2007 and
June 30, 2007, respectively 196,221 196,221
Class B common stock, $.01 par value, 2,000,000
shares authorized, 775,760 issued and outstanding
at September 30, 2007 and June 30, 2007,
respectively, each convertible into one share
of Class A common Stock 7,758 7,758
Additional paid-in capital 26,875,513 26,812,808
Treasury stock, 349,098 shares of Class A
common stock at September 30, 2007 and
199,098 at June 30, 2007, at cost (586,215) (191,700)
Accumulated deficit (7,774,935) (8,574,946)
____________ __________
Total stockholders' equity 18,718,342 18,250,141
____________ __________
Total liabilities and stockholders' equity $26,295,871 $27,289,741
============ ===========
6
PHC, INC. AND SUBSIDIARIES
Consolidated Statements of Income
Three Months Ended September 30,
2007 2006
____ ____
Revenues:
Patient care, net $10,143,435 $ 7,876,432
Pharmaceutical studies 1,420,965 1,051,383
Contract support services 1,139,766 1,134,391
___________ ___________
Total revenues 12,704,166 10,062,206
___________ ___________
Operating expenses:
Patient care expenses 5,296,074 4,054,966
Patient care expenses, pharmaceutical 609,792 486,937
Cost of contract support services 802,648 838,555
Provision for doubtful accounts 422,226 452,525
Administrative expenses 3,609,936 2,996,141
Administrative expenses, pharmaceutical 571,856 679,108
___________ ___________
Total operating expenses 11,312,532 9,508,232
___________ ___________
Income from operations 1,391,634 553,974
___________ ___________
Other income (expense):
Interest income 32,535 32,849
Other (expense) income 14,099 (943)
Interest expense (131,381) (119,830)
___________ ___________
Total other expenses, net (84,747) (87,924)
___________ ___________
Income before provision for taxes 1,306,887 466,050
Provision for income taxes 506,876 182,767
___________ ___________
Net income $ 800,011 $ 283,283
=========== ===========
Basic net income per common share $ 0.04 $ 0.02
=========== ===========
Basic weighted average number of shares
outstanding 20,136,781 18,514,142
=========== ===========
Diluted net income per common share $ 0.04 $ 0.01
=========== ===========
Diluted weighted average number of shares
outstanding
20,601,828 19,296,638
=========== ===========
7